DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Wednesday reported a loss of $18.4 million in its second quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 39 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 44 cents per share.
The biopharmaceutical company posted revenue of $1.2 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $937,000.
The company's shares closed at $4.30. A year ago, they were trading at $4.93.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CMRX at https://www.zacks.com/ap/CMRX